Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents

References

• Bains S. K., Gardiner S. M., Mannweiler K., Gillett D., Gibson G. G. Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid. Biochemical Pharmacology 1985; 34: 3221–3229
   PubMed Web of Science ®Google Scholar
• Barnard S. D., Molello J. A., Caldwell W. J., Le Beau J. E. Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate. Journal of Toxicology and Environmental Health 1980; 6: 547–557
   PubMed Web of Science ®Google Scholar
• Batt A. M., Siest G., Oesch F. Differential regulation of two microsomal epoxide hydrolases in hyperplastic nodules from rat liver. Carcinogenesis 1984; 5: 1205–1206
   PubMedGoogle Scholar
• Burchell B., Blanckaert N. Bilirubin mono- and diglucuronide formation by purified rat liver microsomal bilirubin UDP-glucuronyltransferase. Biochemical Journal 1984; 223: 461–465
   PubMed Web of Science ®Google Scholar
• Chacos N., Falck J. R., Wixtrom C., Capdevila J. Novel epoxides formed during the liver cytochrome P-450 oxidation of arachidonic acid. Biochemical and Biophysical Research Communication 1982; 104: 916–922
   PubMed Web of Science ®Google Scholar
• Colin-Neiger A., Kauffman I., Boutin J. A., Fournel S., Siest G., Batt A. M., Magdalou J. Assessment of the Mulder and Van Doorn kinetic procedure and rapid centrifugal analysis of UDP-glucuronosyltransferase activities. Journal of Biochemical and Biophysical Methods 1984; 9: 69–79
   PubMedGoogle Scholar
• Dansette P. M., Dubois G. C., Jerina D. M. Continuous fluorimetric assay of epoxide hydrolase activity. Analytical Biochemistry 1979; 97: 340–345
   PubMedGoogle Scholar
• Dent J. G., Graichen M. E. Effect of hepatocarcinogens on epoxide hydrolase and other xenobiotic metabolizing enzymes. Carcinogenesis 1982; 3: 733–738
   PubMedGoogle Scholar
• Emudianughe T. S., Caldwell J., Sinclair K. A., Smith R. L. Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man. Drug Metabolism and Disposition 1983; 11: 97–102
   PubMedGoogle Scholar
• Farber E. The biochemistry of preneoplastic liver: a common metabolic pattern in hepatocyte nodules. Canadian Journal of Biochemistry and Cell Biology 1984; 62: 486–494
   PubMedGoogle Scholar
• Fischer G., Ullrich D., Bock K. W. Effects of N-nitrosomorpholine and phenobarbital on UDF-glucuronyltransferase in putative preneoplastic foci of rat liver. Carcinogenesis 1985; 6: 605–609
   PubMed Web of Science ®Google Scholar
• Fournel S., Magdalou J., Thomassin J., Vilioutreix J., Siest G., Caldwell J., Andre J. C. Structure-dependent induction of bilirubin glucuronidation and lauric acid 12-hydroxylation by arylcarboxylic acids chemically related to clofibrate. Biochimica et Biophysica Acta 1985; 842: 202–213
   PubMed Web of Science ®Google Scholar
• Gendre P. M. J., Marcelon G., Delhon A., Lauressergues H., Fauran F. Etude comparative biochimique et ultrastructurale de la réponse hépatique induite chez le rat par deux agents hypolipémiants: clofibrate et itanoxone. Journal de Pharmacologie 1984; 15: 209–222
   PubMedGoogle Scholar
• Hammock B. D., Ota K. Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities. Toxicology and Applied Pharmacology 1983; 71: 254–265
   PubMed Web of Science ®Google Scholar
• Heirwegh K. P. M., Van De Vijver M., Fevery J. Assay and properties of digitonin-activated bilirubin uridine diphosphate glucuronyltransferase from rat liver. Biochemical Journal 1972; 129: 605–618
   PubMed Web of Science ®Google Scholar
• Hess R., Staubli W., Riess W. Nature of the hepatomegalie effect produced by ethyl-chlorophenoxyisobutyrate in the rat. Nature 1965; 208: 856–858
   PubMed Web of Science ®Google Scholar
• Hogeboom G. M. Fractionation of cell components of animal tissues: general method for the isolation of liver cell components. Methods in Enzymology, S. P. Colowick, N. O. Kaplan. Academic Press, New York 1955; vol. 1: 16–19
   Google Scholar
• Kamdem L., Magdalou J., Siest G. Effects of aflatoxin B1 on the activity of drug-metabolizing enzymes in rat liver. Toxicology and Applied Pharmacology 1981; 60: 570–578
   PubMedGoogle Scholar
• Lake B. G., Gray T. J. B., Pels Rijcken W. R., Beamand J. A., Gangolli S. D. The effect of hypolipodaemic agents on peroxisomal B-oxidation and mixed-function oxidase activities in primary cultures of rat hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and lauric acid hydroxylation. Xenobiotica 1984; 14: 269–276
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Matsubara T., Koike M., Touchi A., Tochino Y., Sugeno K. Quantitive determination of cytochrome P-450 in rat liver homogenate. Analytical Biochemistry 1976; 75: 596–603
   PubMed Web of Science ®Google Scholar
• Moody D. E., Reddy J. K., Azarnoff D. L. Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents. Biochemical Pharmacology 1984; 33: 2591–2597
   PubMed Web of Science ®Google Scholar
• Mulder G. J., Van Doorn A. B. D. A rapid NAD+ linked assay for microsomal uridine diphosphate glucuronosyltransferase of rat liver and some observations on substrate specificity of the enzyme. Biochemical Journal 1975; 151: 131–140
   PubMed Web of Science ®Google Scholar
• Neville J. D. M. Isolation of an organ specific protein antigen from cell surface membrane of rat liver. Biochimica et Biophysica Acta 1968; 154: 540–552
   PubMed Web of Science ®Google Scholar
• Okita R., Chance C. Induction of laurate W-hydroxylase by di(2-ethylhexyl)phthalate in rat liver microsomes. Biochemical and Biophysical Research Communications 1984; 121: 304–309
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Lalwani N. D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Critical Reviews in Toxicology 1983; 12: 1–58
   Web of Science ®Google Scholar
• Reddy J. K., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980; 283: 397–398
   PubMed Web of Science ®Google Scholar
• Rutenburg A. M., Him H., Kshbein S. W., Hanker S. S., Wasserkrug H. L., Selignan A. M. Histochemical and ultrastructural demonstration of a gamma-glutamyltransferase activity. Journal of Histochemistry and Cytochemistry 1969; 17: 517–526
   PubMed Web of Science ®Google Scholar
• Sato K., Kitahara A., Yin Z., Ebina T., Satoh K., Tsuda H., Ito N., Dempo K. Molecular forms of glutathione S-transferase and UDP-glucuronyltransferase as hepatic preneoplastic marker enzymes. Annals of the New York Academy of Sciences 1983; 147: 213–222
   Google Scholar
• Stäubli W., Bentley P., Bieri F., Fröhlich E., Waechter F. Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver. Carcinogenesis 1984; 5: 41–46
   PubMed Web of Science ®Google Scholar
• Steinmetz J., Gaspart E., Panek E., Morin C., Drouin P. Effect of hypolipidemics drugs on ten blood constituents. Drug Measurement and Drug Effects in Laboratory Health Science, 4th Int. Coll. Prospective Biology, Pont-à-Mousson, G. Siest, D. S. Young. Karger, Basel 1978; 194–203
   Google Scholar
• Stogniew M., Fenselau C. Electrophilic reactions of acyl-linked glucuronides. Formation of clofibrate mercapturate in humans. Drug Metabolism and Disposition 1982; 10: 609–613
   PubMed Web of Science ®Google Scholar
• Szasz G. A kinetic photometric method for serum gamma-glutamyl-transpeptidase. Clinical Chemistry 1969; 15: 124–136
   PubMed Web of Science ®Google Scholar
• Tamburini P. P., Massan H. A., Bains S. K., Makowski R. J., Morris B., Gibson G. G. Multiple forms of hepatic cytochrome P-450. Purification, characterisation and comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome P-450. European Journal of Biochemistry 1984; 139: 235–246
   PubMedGoogle Scholar
• Thomas W. A., Kim D. N. Biology of disease. Atherosclerosis as a hyperplastic and or neoplastic process. Laboratory Investigation 1983; 48: 245–255
   PubMedGoogle Scholar
• Zhiri A., Muller J., Fournel S., Magdalou J., Wellman-Benawska M., Siest G. A new enzyme immnuoassay of microsomal rat liver epoxide hydrolase. Analytical Biochemistry 1986, in press
   Google Scholar